Articles with "cd271" as a keyword



Photo by paipai90 from unsplash

Comparative characterization of CD271+ and CD271− subpopulations of CD34+ human adipose‐derived stromal cells

Sign Up to like & get
recommendations!
Published in 2018 at "Journal of Cellular Biochemistry"

DOI: 10.1002/jcb.26496

Abstract: Adipose‐derived stromal/stem cells (ASCs) are promising candidates for cell‐based therapies. However, the lack of markers able to unequivocally identify these cells, the differential expression of cell surface molecules among stromal progenitors from different tissues and… read more here.

Keywords: human adipose; derived stromal; cd271; expression ... See more keywords
Photo from wikipedia

CD271 determines migratory properties of melanoma cells

Sign Up to like & get
recommendations!
Published in 2017 at "Scientific Reports"

DOI: 10.1038/s41598-017-10129-z

Abstract: Melanoma cell expression of the nerve growth factor receptor CD271 is associated with stem-like properties. However, the contributing role of the receptor in melanoma cell migration is elusive. Here, we explored extracranial (skin, soft tissue,… read more here.

Keywords: melanoma; melanoma cell; cd271; migration ... See more keywords
Photo from wikipedia

CD271+ Cells Are Diagnostic and Prognostic and Exhibit Elevated MAPK Activity in SHH Medulloblastoma.

Sign Up to like & get
recommendations!
Published in 2018 at "Cancer research"

DOI: 10.1158/0008-5472.can-18-0027

Abstract: The extensive heterogeneity both between and within the medulloblastoma subgroups underscores a critical need for variant-specific biomarkers and therapeutic strategies. We previously identified a role for the CD271/p75 neurotrophin receptor (p75NTR) in regulating stem/progenitor cells… read more here.

Keywords: diagnostic prognostic; shh medulloblastoma; medulloblastoma; cd271 ... See more keywords
Photo from wikipedia

Reactive Oxygen Species Regulation of Chemoresistance and Metastatic Capacity of Melanoma: Role of the Cancer Stem Cell Marker CD271

Sign Up to like & get
recommendations!
Published in 2023 at "Biomedicines"

DOI: 10.3390/biomedicines11041229

Abstract: BRAF mutations are present in 30–50% of cases of cutaneous melanoma, and treatment with selective BRAF and MEK inhibitors has been introduced. However, the development of resistance to these drugs often occurs. Chemo-resistant melanoma cells… read more here.

Keywords: reactive oxygen; cd271; stem cell; melanoma ... See more keywords